UBS AM’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-35,429
Closed -$159K 2808
2024
Q2
$159K Buy
35,429
+23,829
+205% +$242K ﹤0.01% 2765
2024
Q1
$173K Hold
11,600
﹤0.01% 2477
2023
Q4
$168K Hold
11,600
﹤0.01% 2503
2023
Q3
$160K Buy
+11,600
New +$209K ﹤0.01% 2537

Other funds holding BMEA

UBS AM's BMEA Position: Q3 2024 in Review

UBS AM sold out of Biomea Fusion (BMEA) in Q3 2024, closing a stake of 35,429 shares — an estimated $159K sold.

UBS AM first reported a position in BMEA in Q3 2023 and held it in 4 quarters. The position peaked at $173K in Q1 2024. 88 funds tracked by Wall St. Rank hold BMEA as of Q3 2024.

  • UBS AM reported no remaining Biomea Fusion position as of Q3 2024 after selling out during the quarter.
  • UBS AM sold 35,429 Biomea Fusion shares in Q3 2024, an estimated $159K.
  • UBS AM first reported a position in Biomea Fusion in Q3 2023 and held it in 4 quarters.
  • UBS AM's Biomea Fusion position peaked at $173K in Q1 2024.
  • 88 funds tracked by Wall St. Rank held Biomea Fusion as of Q3 2024.

Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.